EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Structural and Functional Aspects of DHPM-Thiones and Their Derivatives: A Critical Review of Pharmaceutical Potential

Artyom Savelyev iD, Dmitriy Khrustalev iD, Irina Losseva iD, Azamat Yedrissov, Anastassiya Khrustaleva iD, Shapovalenko Sofiya iD, Marlen Kiikbayev iD, Rusyaeva Polina, Kazantsev Vladimir iD

Pharmaceuticals · 12.02.2026 · 19 (2) · 306

DOI: 10.3390/ph19020306 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 12.02.2026. Verfasst von Artyom Savelyev und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, NPJSC "Karaganda Medical University", 40 Gogol St., Karaganda 100008, Kazakhstan. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Amidst escalating global challenges such as antimicrobial resistance and post-COVID therapeutic gaps, dihydropyrimidines (DHPs) and their thione derivatives have emerged as a highly promising scaffold for drug development. This systematic review aims to consolidate recent advancements (2020–2025) and evaluate the synthetic innovation, structure–activity relationships (SAR), and preclinical potential of these compounds.

Methods

A systematic review was conducted according to PRISMA guidelines, searching multiple electronic databases (Scopus, PubMed, Web of Science). Sixty original studies from 2020 to 2025 meeting predefined inclusion criteria were selected for data extraction and qualitative synthesis.

Results

The analysis reveals a surge in publications (over 300% since 2020). Key structural modifications, such as N-methylation to improve bioavailability and specific substitutions at C4/C5 positions, significantly enhance biological potency, yielding strong inhibitory effects against viral proteases and cancer cell lines. Notable compounds include the apoptosis inducer LaSOM 65 and multitarget Ru(II)–Biginelli hybrids.

Conclusions

This review affirms the timeliness and translational potential of the DHP scaffold. The field shows bright prospects for advancing to phase I trials by 2030, urging intensified exploration to unlock novel pharmaceuticals from this versatile chemotype.

Schlagwörter

Stichwörter der Autor:innen

DHPM-thionesdihydropyrimidinesmicrowave flow synthesispreclinical potentialstructure–activity relationship

Autor:innen und Institutionen

  • School of Pharmacy, NPJSC "Karaganda Medical University", 40 Gogol St., Karaganda 100008, Kazakhstan.

ORCID-Profile: Artyom Savelyev, Dmitriy Khrustalev, Irina Losseva, Anastassiya Khrustaleva, Shapovalenko Sofiya, Marlen Kiikbayev, Kazantsev Vladimir

Zitieren

APA

Savelyev, A., Khrustalev, D., Losseva, I., Yedrissov, A., Khrustaleva, A., Sofiya, S., Kiikbayev, M., Polina, R., & Vladimir, K. (2026). Structural and Functional Aspects of DHPM-Thiones and Their Derivatives: A Critical Review of Pharmaceutical Potential. Pharmaceuticals, 19(2), 306. https://doi.org/10.3390/ph19020306

Vancouver

Savelyev A, Khrustalev D, Losseva I, Yedrissov A, Khrustaleva A, Sofiya S, et al. Structural and Functional Aspects of DHPM-Thiones and Their Derivatives: A Critical Review of Pharmaceutical Potential. Pharmaceuticals. 2026;19(2):306. doi:10.3390/ph19020306

BibTeX
@article{Savelyev2026,
  author = {Savelyev, Artyom and Khrustalev, Dmitriy and Losseva, Irina and Yedrissov, Azamat and Khrustaleva, Anastassiya and Sofiya, Shapovalenko and Kiikbayev, Marlen and Polina, Rusyaeva and Vladimir, Kazantsev},
  title = {Structural and Functional Aspects of DHPM-Thiones and Their Derivatives: A Critical Review of Pharmaceutical Potential},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {2},
  pages = {306},
  doi = {10.3390/ph19020306}
}
Kostenlos starten →